Implement innovative molecular tumor profiling in your lab
Parallel analysis of tumor mutational burden and driver genes
Molecular analysis of myeloid malignancies
The hybrid capture-based NGS technology allows for the sensitive detection of clinically relevant point mutations, insertions, deletions, copy number alterations, translocations and tumor mutational burden in a single sample – for reliable cancer profiling results.
Our innovative assays for various questions in molecular pathology and clinical research are combined with bioinformatic evaluation and user-friendly data evaluation. Full data control on all raw and analysis files remains with the customer.
The analysis is based exclusively on DNA and enables optimized and tissue-saving processes in the laboratory. In establishing the technology, we offer our customers tailored support for efficient molecular tumor diagnostics.
Molecular cancer diagnostics in your laboratory
Hybrid capture-based next generation sequencing
Media, scientific publications and conference abstracts
The management team of New Oncology
Back to the top